Post-IPO Equity Biotechnology Companies

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

EXACT Therapeutics is a clinical stage biotech firm developing a technology platform for therapeutic enhancement Acoustic Cluster Therapy.

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.

Atlantic Coastal Acquisition Corp. II is a blank check company.

Biora Therapeutics is the biotech company.

Fluicell is one of the manufacturers of fluid platforms for multifunctional pipettes.

ASEP Medical develops a diagnostic assay for the early and rapid diagnosis of sepsis.

Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Aditxt Therapeutics is a biotechnology company that develops a novel nucleic acid-based technology.

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Carvolix is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Elutia is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.

Mereo is a new UK-based speciality biopharmaceutical company.

BCAL Diagnostics is a biotechnology company that focuses on the detection of women’s health issues.

Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.